Cargando…
Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis
CCAAT/enhancer binding protein alpha (CEBPA) mutations in AML are associated with favourable prognosis and are divided into N- and C-terminal mutations. The majority of AML patients have both types of mutations. We assessed the prognostic significance of single (n=7) and double (n=12) CEBPA mutation...
Autores principales: | Pabst, T, Eyholzer, M, Fos, J, Mueller, B U |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676545/ https://www.ncbi.nlm.nih.gov/pubmed/19277035 http://dx.doi.org/10.1038/sj.bjc.6604977 |
Ejemplares similares
-
Reply to ‘Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis’
por: Hou, H-A, et al.
Publicado: (2009) -
The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML
por: Eyholzer, M, et al.
Publicado: (2010) -
Long-term follow-up of cytogenetically normal CEBPA-mutated AML
por: Pastore, Friederike, et al.
Publicado: (2014) -
Unfolded protein response suppresses CEBPA by induction of calreticulin in acute myeloid leukaemia
por: Schardt, Julian A, et al.
Publicado: (2010) -
Germline CEBPA mutation in familial acute myeloid leukemia
por: Boada, Matilde, et al.
Publicado: (2021)